The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Q3 2015 Review with Orgenesis Inc. - Focused on Developing Cure for Type 1 Diabetes

In this SNNLive On-Location, our host spoke with Scott P. Carmer, CEO, North America of Orgenesis Inc. (OTCQB: ORGS) in New York City, NY.

Share With

Tuesday, October 20, 2015

   

© 2017 Stock News Now